```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1446 Introduced in House (IH)]

109th CONGRESS
  1st Session
                                H. R. 1446

  To amend the Controlled Substances Act to eliminate the safe-harbor 
  exception for certain packaged pseudoephedrine products used in the 
        manufacture of methamphetamine, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 17, 2005

    Mr. Souder (for himself, Mr. Burton of Indiana, Mr. Peterson of 
Pennsylvania, Mr. Boehlert, Ms. Bordallo, Mr. Case, and Mr. Kennedy of 
  Minnesota) introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   the Judiciary, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL

 
  To amend the Controlled Substances Act to eliminate the safe-harbor 
  exception for certain packaged pseudoephedrine products used in the 
        manufacture of methamphetamine, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

    (a) Short Title.--This Act may be cited as the ``Methamphetamine 
Abuse Prevention Act of 2005''.
    (b) Table of Contents.--The table of contents of this Act is as 
follows:

Sec. 1. Short title; table of contents.
Sec. 2. Findings.
                  TITLE I--METHAMPHETAMINE PRECURSORS

          Subtitle A--Amendments to Controlled Substances Act

Sec. 101. Regulated transactions in methamphetamine precursor chemical 
                            products.
Sec. 102. Authority to establish production quotas.
Sec. 103. Penalties; authority for manufacturing; quota.
 Subtitle B--Amendments to Controlled Substances Import and Export Act

Sec. 111. Restrictions on importation; authority to permit imports for 
                            medical, scientific, or other legitimate 
                            purposes.
Sec. 112. Notice of importation or exportation; approval of sale or 
                            transfer by importer or exporter.
                     Subtitle C--General Provisions

Sec. 121. Report by Director of Office of National Drug Control Policy 
                            regarding regulation of list I chemicals.
                  TITLE II--RESOURCES FOR ENFORCEMENT

Sec. 201. Authorization of appropriations relating to COPS grants.
Sec. 202. Expansion of methamphetamine hot spots program to include 
                            personnel and equipment for enforcement, 
                            prosecution, and cleanup.
Sec. 203. Special United States attorneys' program.
                       TITLE III--GRANT PROGRAMS

                 Subtitle A--Public Health Service Act

Sec. 301. Grants for services for children of substance abusers.
Sec. 302. Local grants for treatment of methamphetamine abuse and 
                            related conditions.
                     Subtitle B--Bureau of Justice

Sec. 303. Methamphetamine precursor monitoring grants.

SEC. 2. FINDINGS.

    The Congress finds as follows:
            (1) Methamphetamine, ecstasy, and other synthetic drugs are 
        dangerous drugs distributed throughout the United States.
            (2) The manufacture, distribution, and use of 
        methamphetamine and other synthetic drugs result in increased 
        crime, damage to the environment, and hazardous waste that 
        endanger the public, expensive cleanup costs often borne by 
        Federal, State, and local government agencies, and broken 
        families.
            (3) The Congress has acted many times to limit the 
        availability of chemicals and equipment used in the 
        manufacturing of methamphetamine and other synthetic drugs.
            (4) Pseudoephedrine is one of the basic precursor chemicals 
        used in the manufacture of methamphetamine.
            (5) The Drug Enforcement Administration has indicated that 
        methamphetamine manufacturers often obtain pseudoephedrine from 
        retail and wholesale distributors, in both bottles and 
        ``blister packs'', and that the use of pseudoephedrine tablets 
        in blister packs is pervasive in the illicit production of 
        methamphetamine in both small and large clandestine 
        methamphetamine laboratories.
            (6) While current law establishes a retail sales limit of 9 
        grams for most pseudoephedrine products, including common cold 
        medicine, there is no such limit on the sale of blister-packed 
        pseudoephedrine products.
            (7) The 9 gram limit on bottled pseudoephedrine allows an 
        individual to purchase approximately 366 thirty-milligram 
        tablets per transaction, which is significantly more than a 
        typical consumer would need for legitimate purposes.
            (8) Reducing the current 9 gram threshold to 6 grams would 
        allow consumers to continue purchasing sufficient medication 
        for legitimate purposes and would assist efforts to reduce 
        illegal use of the pseudoephedrine products.
            (9) The Drug Enforcement Administration recommended in 
        March 2002 that retail distribution of pseudoephedrine tablets 
        in blister packages should not be exempt from the general 
        retail sales limit.
            (10) In recommending legislation to correct the current 
        disparity in the law between bottled and blister-packed 
        pseudoephedrine tablets, the Drug Enforcement Administration 
        stated that ``The removal of this difference would 
        significantly prevent illicit access to this methamphetamine 
        precursor and would be easier for both the government and the 
        industry to monitor and would increase compliance by 
        retailers''.
            (11) In its October 2004 National Synthetic Drugs Action 
        Plan, the Department of Justice and the Office of National Drug 
        Control Policy also recommended that the manufacture, import, 
        export, and distribution of pseudoephedrine and other synthetic 
        drug precursor chemicals be subject to increased governmental 
        oversight to reduce the danger of diversion to illegal drug 
        production.

                  TITLE I--METHAMPHETAMINE PRECURSORS

          Subtitle A--Amendments to Controlled Substances Act

SEC. 101. REGULATED TRANSACTIONS IN METHAMPHETAMINE PRECURSOR CHEMICAL 
              PRODUCTS.

    (a) Reduction of Retail Sales Threshold.--Section 
102(39)(A)(iv)(II) of the Controlled Substances Act (21 U.S.C. 
802(39)(A)(iv)(II)) is amended by striking ``shall be 9 grams'' and all 
that follows and inserting the following: ``shall be any quantity of 
pseudoephedrine over 6.0 grams in a single transaction, or any quantity 
of phenylpropanolamine over 6.0 grams in a single transaction, which 
quantity is--
                                            ``(aa) with respect to 
                                        nonliquids, sold in package 
                                        sizes of not more than 3.0 
                                        grams of pseudoephedrine base 
                                        or 3.0 grams of 
                                        phenylpropanolamine base, 
                                        respectively, and packaged in 
                                        blister packs, each blister 
                                        containing not more than 2 
                                        dosage units, or where the use 
                                        of blister packs is technically 
                                        infeasible, packaged in unit 
                                        dose packets or pouches; and
                                            ``(bb) with respect to 
                                        liquids, sold in package sizes 
                                        of not more than 3.0 grams of 
                                        pseudoephedrine base, or 3.0 
                                        grams of phenylpropanolamine 
                                        base, respectively; or''.
    (b) Elimination of Blister Pack Exemption.--
            (1) Regulated transaction.--Section 102(39)(A)(iv)(I)(aa) 
        of the Controlled Substances Act (21 U.S.C. 
        802(39)(A)(iv)(I)(aa)) is amended by striking ``, except that'' 
        and all that follows through ``1996)''.
            (2) Definition.--Section 102 of the Controlled Substances 
        Act (21 U.S.C. 802) is amended--
                    (A) by striking paragraph (45); and
                    (B) by redesignating paragraph (46) as paragraph 
                (45).
            (3) Rule of law.--To the extent that there exists a 
        conflict between the amendment made by paragraph (1) and 
        section 401(d) of the Comprehensive Methamphetamine Control Act 
        of 1996 (21 U.S.C. 802 note), the amendment shall control.
    (c) Combinations Involving Derivatives.--Section 102(39) of the 
Controlled Substances Act (21 U.S.C. 802(39)) is amended--
            (1) in subparagraph (A)(iv)(I)(aa), by striking ``the drug 
        contains'' and all that follows through ``unless otherwise 
        provided'' and inserting the following: ``the drug contains 
        ephedrine, pseudoephedrine, or phenylpropanolamine unless 
        otherwise provided''; and
            (2) by inserting after and below subparagraph (B) the 
        following:
        ``Each reference in subparagraph (A)(iv) to ephedrine, 
        pseudoephedrine, or phenylpropanolamine includes each of the 
        salts, optical isomers, and salts of optical isomers of such 
        chemical.''.

SEC. 102. AUTHORITY TO ESTABLISH PRODUCTION QUOTAS.

    Section 306 of the Controlled Substances Act (21 U.S.C. 826) is 
amended--
            (1) in subsection (a), by inserting ``and for ephedrine, 
        pseudoephedrine, and phenylpropanolamine'' after ``for each 
        basic class of controlled substance in schedules I and II'';
            (2) in subsection (b), by inserting ``or for ephedrine, 
        pseudoephedrine, or phenylpropanolamine'' after ``for each 
        basic class of controlled substance in schedule I or II'' each 
        place such term appears;
            (3) in subsection (c), in the first sentence, by inserting 
        ``and for ephedrine, pseudoephedrine, and phenylpropanolamine'' 
        after ``for the basic classes of controlled substances in 
        schedules I and II'';
            (4) in subsection (d), by inserting ``or ephedrine, 
        pseudoephedrine, or phenylpropanolamine'' after ``that basic 
        class of controlled substance'';
            (5) in subsection (e), by inserting ``or for ephedrine, 
        pseudoephedrine, or phenylpropanolamine'' after ``for a basic 
        class of controlled substance in schedule I or II'' each place 
        such term appears;
            (6) in subsection (f)--
                    (A) by inserting ``or ephedrine, pseudoephedrine, 
                or phenylpropanolamine'' after ``controlled substances 
                in schedules I and II'';
                    (B) by inserting ``or of ephedrine, 
                pseudoephedrine, or phenylpropanolamine'' after ``the 
                manufacture of a controlled substance''; and
                    (C) by inserting ``or chemicals'' after ``such 
                incidentally produced substances''; and
            (7) by adding at the end the following subsection:
    ``(g) Each reference in this section to ephedrine, pseudoephedrine, 
or phenylpropanolamine includes each of the salts, optical isomers, and 
salts of optical isomers of such chemical.''.

SEC. 103. PENALTIES; AUTHORITY FOR MANUFACTURING; QUOTA.

    Section 402(b) of the Controlled Substances Act (21 U.S.C. 842(b)) 
is amended by inserting after ``manufacture a controlled substance in 
schedule I or II'' the following: ``, or ephedrine, pseudoephedrine, or 
phenylpropanolamine or any of the salts, optical isomers, or salts of 
optical isomers of such chemical,''

 Subtitle B--Amendments to Controlled Substances Import and Export Act

SEC. 111. RESTRICTIONS ON IMPORTATION; AUTHORITY TO PERMIT IMPORTS FOR 
              MEDICAL, SCIENTIFIC, OR OTHER LEGITIMATE PURPOSES.

    Section 1002(a) of the Controlled Substances Import and Export Act 
(21 U.S.C. 952(a)) is amended--
            (1) in the matter preceding paragraph (1), by inserting 
        ``or ephedrine, pseudoephedrine, or phenylpropanolamine,'' 
        after ``schedule III, IV, or V of title II,'';
            (2) in paragraph (1), by inserting ``, and of ephedrine, 
        pseudoephedrine, and phenylpropanolamine, '' after ``coca 
        leaves''; and
            (3) by adding at the end the following subsections:
    ``(d)(1) With respect to a registrant under section 1008 who is 
authorized under subsection (a)(1) to import ephedrine, 
pseudoephedrine, or phenylpropanolamine, at any time during the year 
the registrant may apply for an increase in the amount of such chemical 
that the registrant is authorized to import, and the Attorney General 
may approve the application if the Attorney General determines that the 
approval is necessary to provide for medical, scientific, or other 
legitimate purposes regarding the chemical.
    ``(2) Not later than 60 days after receiving an application under 
paragraph (1), the Attorney General shall approve or deny the 
application. In approving such an application, the Attorney General 
shall specify the period of time for which the approval is in effect, 
or shall provide that the approval is effective until the registrant 
involved is notified by the Attorney General that the approval is 
terminated.
    ``(e) Each reference in this section to ephedrine, pseudoephedrine, 
or phenylpropanolamine includes each of the salts, optical isomers, and 
salts of optical isomers of such chemical.''.

SEC. 112. NOTICE OF IMPORTATION OR EXPORTATION; APPROVAL OF SALE OR 
              TRANSFER BY IMPORTER OR EXPORTER.

    (a) In General.--Section 1018 of the Controlled Substances Import 
and Export Act (21 U.S.C. 971) is amended--
            (1) by redesignating subsections (d) and (e) as subsections 
        (e) and (f), respectively; and
            (2) by inserting after subsection (c) the following 
        subsection:
    ``(d)(1)(A) Information provided in a notice under subsection (a) 
shall include the name of the person to whom the importer or exporter 
involved intends to transfer the listed chemical involved.
    ``(B) After a notice under subsection (a) is provided to the 
Attorney General, if circumstances change and the importer or exporter 
will not be transferring the listed chemical to the transferee 
identified in the notice, the importer or exporter may not transfer the 
listed chemical until after the expiration of the 15-day period 
beginning on the date on which the importer or exporter updates the 
notice to identify the most recent prospective transferee. The 
preceding sentence applies with respect to changing circumstances 
regarding a transferee identified in an update to the same extent and 
in the same manner as such sentence applies with respect to changing 
circumstances regarding a transferee identified in a notice under 
subsection (a).
    ``(C) If in reliance on subsection (b) an importer or exporter does 
not provide a notice under subsection (a) with respect to an 
importation or exportation, but circumstances change and the importer 
or exporter will not be transferring the listed chemical to a regular 
customer, the importer or exporter may not transfer the listed chemical 
until after the expiration of the 15-day period beginning on the date 
on which the importer or exporter notifies the Attorney General of the 
most recent prospective transferee. The preceding sentence applies with 
respect to changing circumstances regarding a transferee identified in 
a notice under such sentence to the same extent and in the same manner 
as such sentence applies with respect to the original changing 
circumstances in which the listed chemical was not transferred to a 
regular customer.
    ``(2) With respect to the transfer of a listed chemical by an 
importer or exporter:
            ``(A) The Attorney General may, in accordance with the same 
        procedures as apply under subsection (c)(2), order the 
        suspension of a transfer of the listed chemical by the importer 
        or exporter, other than a transfer to a regular customer of the 
        importer or exporter, on the ground that the chemical may be 
        diverted to the illegal or clandestine manufacture of a 
        controlled substance, subject to the Attorney General ordering 
        such suspension before the expiration of the 15-day period that 
        applies with respect to the importation or exportation under 
        subparagraph (B) or (C) of paragraph (1), as the case may be.
            ``(B) From and after the time when the Attorney General 
        provides written notice of the order under subparagraph (A) 
        (including a statement of the legal and factual basis for the 
        order) to the importer or exporter, the importer or exporter 
        may not carry out the transfer.
    ``(3) For purposes of this subsection:
            ``(A) The terms `importer' and `exporter' mean a regulated 
        person who imports or exports a listed chemical, respectively.
            ``(B) The term `transfer', with respect to a listed 
        chemical, includes the sale of the chemical.
            ``(C) The term `transferee' means a person to whom an 
        importer or exporter transfers a listed chemical.''.
    (b) Conforming Amendment.--Section 1010(d)(5) of the Controlled 
Substances Import and Export Act (21 U.S.C. 960(d)(5)) is amended by 
striking ``section 1018(e)(2) or (3)'' and inserting ``paragraph (2) or 
(3) of section 1018(f)''.

                     Subtitle C--General Provisions

SEC. 121. REPORT BY DIRECTOR OF OFFICE OF NATIONAL DRUG CONTROL POLICY 
              REGARDING REGULATION OF LIST I CHEMICALS.

    Not later than one year after the date of the enactment of this 
Act, the Director of the Office of National Drug Control Policy, in 
consultation with the Attorney General, shall submit to the Congress a 
report that--
            (1) provides a recommendation by the Director of whether 
        some or all list I chemicals should be included in schedule V 
        of the schedules of controlled substances; and
            (2) provides such additional recommendations regarding the 
        regulation of list I chemicals as the Director elects to 
        provide to the Congress.

                  TITLE II--RESOURCES FOR ENFORCEMENT

SEC. 201. AUTHORIZATION OF APPROPRIATIONS RELATING TO COPS GRANTS.

    (a) In General.--In addition to any other funds authorized to be 
appropriated for fiscal year 2006 for grants under part Q of title I of 
the Omnibus Crime Control and Safe Streets Act of 1968 (42 U.S.C. 
3796dd et seq.), commonly known as the COPS program, there are 
authorized to be appropriated $15,000,000 for such purpose to provide 
training to State and local prosecutors and law enforcement agents for 
the investigation and prosecution of methamphetamine offenses.
    (b) Rural Set-Aside.--Of amounts made available under subsection 
(a), $3,000,000 shall be available only for prosecutors and law 
enforcement agents for rural communities.

SEC. 202. EXPANSION OF METHAMPHETAMINE HOT SPOTS PROGRAM TO INCLUDE 
              PERSONNEL AND EQUIPMENT FOR ENFORCEMENT, PROSECUTION, AND 
              CLEANUP.

    Section 1701(d) of the Omnibus Crime Control and Safe Streets Act 
of 1968 (42 U.S.C. 3796dd(d)) is amended--
            (1) in paragraph (11) by striking ``and'' at the end;
            (2) in paragraph (12) by striking the period at the end and 
        inserting ``; and''; and
            (3) by adding at the end the following:
            ``(13) hire personnel and purchase equipment to assist in 
        the enforcement and prosecution of methamphetamine offenses and 
        the cleanup of methamphetamine-affected areas.''.

SEC. 203. SPECIAL UNITED STATES ATTORNEYS' PROGRAM.

    (a) In General.--The Attorney General shall allocate any amounts 
appropriated pursuant to the authorization under subsection (c) for the 
hiring and training of special assistant United States attorneys.
    (b) Use of Funds.--The funds allocated under subsection (a) shall 
be used to--
            (1) train local prosecutors in techniques used to prosecute 
        methamphetamine cases, including the presentation of evidence 
        related to the manufacture of methamphetamine;
            (2) train local prosecutors in Federal and State laws 
        involving methamphetamine manufacture or distribution;
            (3) cross-designate local prosecutors as special assistant 
        United States attorneys; and
            (4) hire additional local prosecutors who--
                    (A) with the approval of the United States 
                attorney, shall be cross-designated to prosecute both 
                Federal and State methamphetamine cases; and
                    (B) shall be assigned a caseload, whether in State 
                court or Federal court, that gives the highest priority 
                to cases in which--
                            (i) charges related to methamphetamine 
                        manufacture or distribution are submitted by 
                        law enforcement for consideration; and
                            (ii) the defendant has been previously 
                        convicted of a crime related to methamphetamine 
                        manufacture or distribution.
    (c) Authorization of Appropriations.--There are authorized to be 
appropriated $5,000,000 for each of the fiscal years 2006 and 2007 to 
carry out the provisions of this section.

                       TITLE III--GRANT PROGRAMS

                 Subtitle A--Public Health Service Act

SEC. 301. GRANTS FOR SERVICES FOR CHILDREN OF SUBSTANCE ABUSERS.

    Section 519 of the Public Health Service Act (42 U.S.C. 290bb-25) 
is amended--
            (1) in subsection (b), by inserting after paragraph (8) the 
        following:
            ``(9) Development of drug endangered children rapid 
        response teams that will intervene on behalf of children 
        exposed to methamphetamine as a result of residing or being 
        present in a home-based clandestine drug laboratory.''; and
            (2) in subsection (o)--
                    (A) by striking ``For the purpose'' and inserting 
                the following:
            ``(1) In general.--For the purpose''; and
                    (B) by adding at the end the following:
            ``(2) Drug endangered children rapid response teams.--There 
        are authorized to be appropriated $2,500,000 for each of the 
        fiscal years 2006 and 2007 to carry out the provisions of 
        subsection (b)(9).''.

SEC. 302. LOCAL GRANTS FOR TREATMENT OF METHAMPHETAMINE ABUSE AND 
              RELATED CONDITIONS.

    Subpart 1 of part B of title V of the Public Health Service Act (42 
U.S.C. 290bb et seq.) is amended--
            (1) by redesignating the section 514 that relates to 
        methamphetamine and appears after section 514A as section 514B;
            (2) in section 514B, as redesignated--
                    (A) by amending subsection (a)(1) to read as 
                follows:
            ``(1) Grants authorized.--The Secretary may award grants to 
        States, political subdivisions of States, American Indian 
        Tribes, and private, nonprofit entities to provide treatment 
        for methamphetamine abuse.'';
                    (B) by amending subsection (b) to read as follows:
    ``(b) Priority for Rural Areas.--In awarding grants under 
subsection (a), the Secretary shall give priority to entities that will 
serve rural areas experiencing an increase in methamphetamine abuse.''; 
and
                    (C) in subsection (d)(1), by striking ``2000'' and 
                all that follows and inserting ``2005 and such sums as 
                may be necessary for each of fiscal years 2006 through 
                2009''; and
            (3) by inserting after section 514B, as redesignated, the 
        following:

``SEC. 514C. METHAMPHETAMINE RESEARCH, TRAINING, AND TECHNICAL 
              ASSISTANCE CENTER.

    ``(a) Program Authorized.--The Secretary, acting through the 
Administrator, and in consultation with the Director of the National 
Institutes of Health, shall award grants to, or enter into contracts 
with, public or private, nonprofit entities to establish a research, 
training, and technical assistance center to carry out the activities 
described in subsection (d).
    ``(b) Application.--A public or private, nonprofit entity seeking a 
grant or contract under subsection (a) shall submit an application to 
the Secretary at such time, in such manner, and containing such 
information as the Secretary may require.
    ``(c) Condition.--In awarding grants or entering into contracts 
under subsection (a), the Secretary shall ensure that not less than 1 
of the centers will focus on methamphetamine abuse in rural areas.
    ``(d) Authorized Activities.--Each center established under this 
section shall--
            ``(1) engage in research and evaluation of the 
        effectiveness of treatment modalities for the treatment of 
        methamphetamine abuse;
            ``(2) disseminate information to public and private 
        entities on effective treatments for methamphetamine abuse;
            ``(3) provide direct technical assistance to States, 
        political subdivisions of States, and private entities on how 
        to improve the treatment of methamphetamine abuse; and
            ``(4) provide training on the effects of methamphetamine 
        use and on effective ways of treating methamphetamine abuse to 
        substance abuse treatment professionals and community leaders.
    ``(e) Reports.--Each grantee or contractor under this section shall 
annually submit a report to the Administrator that contains--
            ``(1) a description of the previous year's activities of 
        the center established under this section;
            ``(2) effective treatment modalities undertaken by the 
        center; and
            ``(3) evidence to demonstrate that such treatment 
        modalities were successful.
    ``(f) Authorization of Appropriations.--There are authorized to be 
appropriated to carry out this section $3,000,000 for fiscal year 2006 
and such sums as may be necessary for each of fiscal years 2007 and 
2008.''.

                     Subtitle B--Bureau of Justice

SEC. 303. METHAMPHETAMINE PRECURSOR MONITORING GRANTS.

    (a) Grants Authorized.--The Attorney General, acting through the 
Bureau of Justice Assistance, may award grants to States to establish 
methamphetamine precursor monitoring programs.
    (b) Purpose.--The purpose of the grant program established under 
this section is to--
            (1) prevent the sale of methamphetamine precursors, such as 
        pseudoephedrine, to individuals in quantities so large that the 
        only reasonable purpose of the purchase would be to manufacture 
        methamphetamine;
            (2) educate businesses that legally sell methamphetamine 
        precursors of the need to balance the legitimate need for 
        lawful access to medication with the risk that those substances 
        may be used to manufacture methamphetamine; and
            (3) recalibrate existing prescription drug monitoring 
        programs designed to track the sale of controlled substances to 
        also track the sale of pseudoephedrine in any amount greater 
        than 6 grams.
    (c) Use of Grant Funds.--Grant funds awarded to States under this 
section may be used to--
            (1) implement a methamphetamine precursor monitoring 
        program, including hiring personnel and purchasing computer 
        hardware and software designed to monitor methamphetamine 
        precursor purchases;
            (2) expand existing methamphetamine precursor or 
        prescription drug monitoring programs to accomplish the 
        purposes described in subsection (b);
            (3) pay for training and technical assistance for law 
        enforcement personnel and employees of businesses that lawfully 
        sell substances, which may be used as methamphetamine 
        precursors;
            (4) improve information sharing between adjacent States 
        through enhanced connectivity; or
            (5) make grants to subdivisions of the State to implement 
        methamphetamine precursor monitoring programs.
    (d) Application.--Any State seeking a grant under this section 
shall submit an application to the Attorney General at such time, in 
such manner, and containing such information as the Attorney General 
may require.
    (e) Authorization of Appropriations.--There are authorized to be 
appropriated $5,000,000 for each of the fiscal years 2006 and 2007 to 
carry out the provisions of this section.
                                 <all>
```